Related Experiment Video
Updated: Jan 8, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
A novel cryptographic framework and mathematical modeling for secure transmission of Parkinson's disease data using
Thalapathiraj Sambandham1, Hari Mohan Srivastava2,3,4,5,6,7, Stalin Thangamani8
1Department of Mathematics, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Chennai, 600026, India.
None:
The secure transmission of medical data is an essential requirement in modern telemedicine systems, particularly for chronic neurological disorders such as Parkinson's disease. This paper proposes a novel hybrid cryptographic framework that combines RSA encryption with block-based secret sharing enhanced by a Hilbert matrix-driven mathematical model. The framework introduces dynamic block-wise key generation and adaptive sharing to strengthen data confidentiality and robustness against cryptanalytic attacks. Mathematical modeling is employed to analyze encryption stability, numerical conditioning of the Hilbert matrix, and the diffusion properties of the key space. The proposed method is validated using publicly available Parkinson's EEG and spiral drawing datasets, with quantitative analysis including encryption/decryption time, computational overhead, and image quality metrics (PSNR, SSIM). The framework is further benchmarked against AES-Shamir and ECC-based hybrid models. Experimental results indicate that the proposed system achieves higher security entropy and lower computational cost, making it suitable for deployment in resource-constrained medical IoT environments.
More Related Videos
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
08:59Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...